This page was printed from the Northern & Eastern Devon Formulary and Referral site at
Please ensure you are using the current version of this document
The routine commissioning of Relvar® Ellipta® combination inhaler is accepted in Devon for the regular treatment of asthma in adults and adolescents aged 12 years and older. Formulary Interface Groups should include this in locally defined treatment recommendations.
The full policy can be accessed here